Product Information
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.2146 per EA under NDC 72578011301. Its NADAC has been published 111 times since Jul 10, 2024.
FDA first approved this application on Nov 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB
bisoprolol fumarate and hydrochlorothiazideStrength
2.5; 6.25 mg/1; mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578011301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215666FDA Approved
11/4/2022
TE Code
AB
On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 111 times since Jul 10, 2024, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2146 per EA |
|---|---|
| All-time high | $0.2532 (Sep 11, 2024) |
| All-time low | $0.1729 (Nov 20, 2024) |
| 52-week high | $0.2146 |
| 52-week low | $0.1855 |
| Median price | $0.2056 |
| Average price | $0.2067 |
| Largest weekly change | +35.4% (Aug 21, 2024) |
| Weeks tracked | 111 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by Viona Pharmaceuticals Inc., is $0.2146 per EA (NDC 72578011301), effective Aug 19, 2026.
How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has declined 14.1%. It has been tracked across 111 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
Since Jul 10, 2024, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.1729 (Nov 20, 2024) to a high of $0.2532 (Sep 11, 2024), with a median of $0.2056 per EA.
Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 72578011301) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.